PT - JOURNAL ARTICLE AU - Aleta, Alberto AU - Moreno, Yamir TI - Evaluation of the potential incidence of COVID-19 and effectiveness of contention measures in Spain: a data-driven approach AID - 10.1101/2020.03.01.20029801 DP - 2020 Jan 01 TA - medRxiv PG - 2020.03.01.20029801 4099 - http://medrxiv.org/content/early/2020/03/10/2020.03.01.20029801.short 4100 - http://medrxiv.org/content/early/2020/03/10/2020.03.01.20029801.full AB - Our society is currently experiencing an unprecedented challenge, managing and containing an outbreak of a new coronavirus disease known as COVID-19. While China - where the outbreak started - seems to have been able to contain the growth of the epidemic, different outbreaks are nowadays being detected in multiple countries. Much is currently unknown about the natural history of the disease, such as a possible asymptomatic spreading or the role of age in both the susceptibility and mortality of the disease. Nonetheless, authorities have to take action and implement contention measures, even if not everything is known. To facilitate this task, we have studied the effect of different containment strategies that can be put into effect. Our work specifically refers to the situation in Spain as of February 28th, 2020, where a few dozens of cases have been detected. We implemented an SEIR-metapopulation model that allows tracing explicitly the spatial spread of the disease through data-driven stochastic simulations. Our results are in line with the most recent recommendations from the World Health Organization, namely, that the best strategy is the early detection and isolation of individuals with symptoms, followed by interventions and public recommendations aimed at reducing the transmissibility of the disease, which although not efficacious for disease eradication, would produce as a second order effect a delay of several days in the raise of the number of infected cases.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYM acknowledges partial support from the Government of Aragon, Spain through grant E36-17R (FENOL), and by MINECO and FEDER funds (FIS2017-87519-P). AA and YM acknowledge support from Intesa Sanpaolo Innovation Center. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is freely available from the authors or the sources reported in the manuscript.